STAT+: A new ranking of pharma companies by R&D performance

Eli Lilly ranked first in two categories for R&D performance, while Relay Therapeutics reported promising Phase 2 data for its drug zovegalisib. This led to a 9% increase in company shares during premarket trading. IDEA Pharma conducts the annual ranking of pharma companies.